Related Stories

Pharmacy Board Limits Chloroquine Prescriptions - 08/05/2020

Per the National Institutes of Health (NIH) COVID-19 Treatment Guidelines, which cites insufficient clinical data, the Texas Medical Association COVID-19 Task Force recommends against using chloroquine or hydroxychloroquine to treat COVID-19, “except in a clinical trial.”


TMB Sets Rules on Acute-Pain Scrip Limit, Opioid CME - 07/31/2020

Texas’ pain management requirements underwent several important changes by law in the past year. Now, the Texas Medical Board has issued rules clarifying what prescribers must do to comply with those laws.


How to Prescribe Controlled Substances Under COVID-19 Waivers - 07/02/2020

If you treat patients with chronic pain, you can temporarily prescribe certain controlled substances during a telemedicine visit under state and federal waivers issued in response to the COVID-19 pandemic.


Prescription Monitoring Program: Is Your EHR Connected? - 06/12/2020

Beginning March 1, 2020, all prescribers must set up an account with the Texas Prescription Monitoring Program, known as PMP Aware, and check the PMP prior to prescribing opioids, benzodiazepines, barbiturates, or carisoprodol.


The PMP Requirement Begins - 02/28/2020

With EHR integration in place, physicians must check the state prescription monitoring program (PMP) prior to prescribing an opioid starting March 1.


PMP Checks Won’t Be Necessary for In-Facility Medications, TMB Says - 02/21/2020

Thanks to Texas Medical Association advocacy, the Texas Medical Boardhas refocused its guidance on when physicians will be required to check the Texas Prescription Monitoring Program (PMP) before prescribing certain medications starting March 1.


Making Prescribing Less Painful for Physicians - 02/15/2020

I won’t be surprised if physicians around the state are feeling a little angst and anger over the coming March 1 requirement for physicians to check the Texas prescription monitoring program (PMP) before writing prescriptions for opioids, benzodiazepines, barbiturates, and carisoprodol. I don’t fault them one bit. This is just one more administrative burden placed on physicians. But I want all of you to understand just how much worse it would have been without the intervention of the Texas Medical Association.


Did You Receive an Email Requiring Registration to the State’s PMP? - 02/05/2020

TMA can confirm that an email sent Friday afternoon asking physicians to register for a PMP Aware account are indeed legitimate; however, there is no deadline to register.


Your Video Guide to Texas' New Prescription Drug Monitoring Program - 02/05/2020

In an effort to address the very real and debilitating crisis caused by the misuse of  pain medicines, the Texas Legislature has passed legislation to mandate that all prescribers and pharmacists check the state's Prescription Drug Monitoring Program (PDMP) before prescribing or dispensing certain medications.


Removing the Pain from Prescribing Pain Meds - 11/07/2019

If you prescribe opioids for chronic pain, there are things you need to know to protect your patients as well as your practice, including knowing which patients need drug monitoring and what type of monitoring should be implemented. Thankfully, the Texas Medical Association’s new e-book, Monitoring Opioid Therapy for Chronic Pain, serves as a brief resource for that information and more.


Easing the Pain? Opioid Settlement Brings Valuable Funding to Fight Crisis - 11/01/2019

September 2019 brought what could become a major victory for the state’s handling of opioid addiction. Drug-maker Purdue Pharma – which faced thousands of lawsuits from cities and states, including Texas, for its role in the national opioid crisis – announced it had agreed to a settlement with 24 state attorneys general and other plaintiffs. The maker of OxyContin and other pain drugs says the agreement will provide more than $10 billion to address the epidemic.


No Cannabis for Pregnant Women or New Mothers, FDA Warns - 10/22/2019

Texas physicians are encouraged to help the U.S. Food and Drug Administration spread the word to pregnant and breast-feeding mothers to avoid using cannabis and cannabis-derived products.


Help Promote National Drug Prescription Take Back Day on Oct. 26 - 10/22/2019

Prescription Drug Take Back Day, which allows people to dispose of prescription drugs safely and anonymously, is scheduled for Oct. 26 at locations throughout the state.


Tapering a Patient’s Opioid Dosage? Follow This Guide - 10/18/2019

In an effort to curb the nationwide opioid epidemic while keeping patients from excessive pain, the U.S. Department of Health and Human Services last week published a guide for physicians considering or initiating a reduction in opioid dosage.


TMA Urges Public Education As Hemp-Based Products Become Legal - 10/16/2019

State health officials should take steps to ensure that a new law that legalizes the production and sale of hemp and some hemp products helps Texas physicians protect the health of patients who use those products. The Texas Medical Association sent that message in a letter last week to the Department of State Health Services, which was taking comments related to implementation of House Bill 1325.


Prevention of Opioid Abuse Through Education - 10/15/2019

HB 405 was written to require collaborative efforts and involve many stakeholders who are involved in the health and well-being of mothers and infants across our state. This is the best way to ensure that as many women as possible hear about NAS and its harmful outcomes. Creating more awareness of what causes NAS and potential impacts of the condition will only help our state become a better place for all mothers and babies. HB 405 would help bring needed attention and resources to help educate our state on NAS.


Physicians Need to Prepare for New Opioid Rules and Best Practices - 10/09/2019

Texas physicians need to prepare for changes in state law tied to opioid prescribing in the coming months, according to the three-physician panel that addressed "Responding to the Opioid Epidemic" at the 2019 Texas Medical Association Fall Conference.


The Changing Face of the Opioid Epidemic - 09/27/2019

Opioid abuse and overdose deaths continue to rise in the U.S., with more than 46,000 opioid-related deaths in 2017, up from 5,000 in 2000, data show. But the problem can’t be explained in total deaths alone. The crisis also has changed in character since 2001, new data show.


Opioids and Pharmacy: PMP Extension Granted - 09/16/2019

When it came to opioids and pharmacy matters, some of the major pieces of medicine’s 2019 agenda came down to something everyone wishes they had more of: time. Physicians need it to get comfortable with a mandate to check the state’s prescription monitoring program (PMP). Patients need it to make sure the pain medications they’re prescribed do what the drugs are supposed to do. The legislature listened, and TMA achieved wins on both counts, as well as on increased transparency from pharmacy benefit managers (PBMs).


Opioids, Telemedicine, Legislative Update to Highlight TMA Fall Conference - 09/10/2019

Physicians Meet to Address Health Care Priorities. Navigating the opioid crisis, using telemedicine to expand a medical practice and help more patients, and top issues from the 2019 Texas Legislature highlight the 2019 Texas Medical Association (TMA) Fall Conference. 


TMB Clarifies New 10-Day Limit on Opioids - 08/30/2019

The Texas Medical Board is trying to head off confusion about the state’s new 10-day opioid prescribing limit for acute pain, which takes effect on Sunday. TMB’s statement, released Friday, appears to address concerns that the new law means acute pain patients must be completely cut off from opioids beyond the 10-day mark. That’s not the case, according to the statement.


$18 Million Grants to Help Texas Fight Opioid Abuse - 08/12/2019

More than 70 Texas health institutions have received almost $18 million in federal funds to combat the ongoing nationwide opioid epidemic.


New Laws Improve Opioid Prescription Process in Texas - 08/06/2019

The 2019 Texas Legislature enacted three new laws that will change the way physicians prescribe opioids, including House Bill 3284, which delays the mandate for physicians check the state’s prescription monitoring program, known as PMP Aware, for prescriptions tied to opioids, benzodiazepines, barbiturates, and carisoprodol. The bill pushes back the requirement from Sept. 1, 2019, to March 1, 2020.


New Electronic Form To Be Used To Report Certain Drug Overdoses - 08/06/2019

The Texas Department of State Health Services (DSHS) has created an online form for physicians and other health care professionals to report overdoses from controlled substances such as opioids, cocaine, and methamphetamines. The new electronic form is expected to make reporting and collecting overdose data more efficient, DSHS officials said.


When Do New Opioid Prescribing Requirements Take Effect? - 08/02/2019

To combat the ongoing opioid crisis, state lawmakers passed several measures that change how physicians and other health care professionals will prescribe opioids. However, provisions of the laws take effect at different times, so prescribers should be aware of the deadlines and effective dates of each requirement. Below is a chart showing when each provision takes effect.